https://www.selleckchem.com/products/CAL-101.html
59%, = 0.008), had more changes in place of care during the last two weeks of life ( 0.0001) and died more often in acute hospitals (34% vs. 14%, 0.0001). For the subgroup with access to palliative care, the hospital deaths for individuals with and without a COVID-19 diagnosis were 11% and 4%, respectively ( = 0.008). Cancer patients dying with a COVID-19 diagnosis were older, more often male, and had more comorbidities. A COVID-19 diagnosis negatively affected the probability of being admitted to specialized palliative ca
Like
Comment
Share
